YAZICI, O. Et Al. 2015. Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer. 18th ECCO-40th ESMO Congress .

YAZICI, O., AKSOY, S., ŞENDUR, M. A. N., ÖZDEMİR, N., Akinci, M. B., ZENGİN, N., ... ALTUNDAĞ, M. K.(2015). Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer . 18th ECCO-40th ESMO Congress

YAZICI, OZAN Et Al. "Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer," 18th ECCO-40th ESMO Congress, 2015

YAZICI, OZAN Et Al. "Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer." 18th ECCO-40th ESMO Congress , 2015

YAZICI, O. Et Al. (2015) . "Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer." 18th ECCO-40th ESMO Congress .

@conferencepaper{conferencepaper, author={OZAN YAZICI Et Al. }, title={Study of the impact of Charlson comorbidity index on the efficacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer}, congress name={18th ECCO-40th ESMO Congress}, city={}, country={}, year={2015}}